美国 · 股市与财经 · The Motley Fool

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

来源：The Motley Fool · 美国 8 小时前

Earlier this week, the U.S. Food and Drug Administration (FDA) approved AbbVie 's ( ABBV +1.11%) Juvmo (tavapadon). This is a once-daily pill for adults with Parkinson's disease…

在 The Motley Fool 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.fool.com)

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

推荐阅读

Top Performing Stocks

Ramp's Broadway musical was the worst show I've ever seen. I'm still glad it exists.

10 U.S. cities where it takes the biggest paycheck to buy a home

Trump Says Economy Has ‘Public Relations’ Problem Amid High Prices and Slow Hiring

America’s data center fight is a preview of what's to come for the rest of the world

‘Don’t Screw Up Your Rollover’: Before rolling over your 401(k), check withdrawal options, tax breaks you could be giving up

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

分享

推荐阅读

Top Performing Stocks

Ramp's Broadway musical was the worst show I've ever seen. I'm still glad it exists.

10 U.S. cities where it takes the biggest paycheck to buy a home

Trump Says Economy Has ‘Public Relations’ Problem Amid High Prices and Slow Hiring

America’s data center fight is a preview of what's to come for the rest of the world

‘Don’t Screw Up Your Rollover’: Before rolling over your 401(k), check withdrawal options, tax breaks you could be giving up